Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Miriam R. Lieberman"'
Autor:
Jonathan I. Silverberg, Israel Zyskind, Hiam Naiditch, Jason Zimmerman, Aaron E. Glatt, Abraham Pinter, Elitza S. Theel, Michael J. Joyner, D. Ashley Hill, Miriam R. Lieberman, Elliot Bigajer, Daniel Stok, Elliot Frank, Avi Z. Rosenberg
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
Background COVID-19 can cause some individuals to experience chronic symptoms. Rates and predictors of chronic COVID-19 symptoms are not fully elucidated. Objective To examine occurrence and patterns of post-acute sequelae of SARS-CoV2 infection (PAS
Externí odkaz:
https://doaj.org/article/fc499088cfbb40fdb0eae7a53381fe41
Autor:
Hiam Naiditch, Elliot Bigajer, D. Ashley Hill, Avi Z. Rosenberg, Michael J. Joyner, Daniel Stok, Miriam R. Lieberman, Abraham Pinter, Jonathan I. Silverberg, Elitza S. Theel, Israel Zyskind, Aaron E. Glatt, Jason Zimmerman, Elliot Frank
Publikováno v:
The Journal of Allergy and Clinical Immunology. in Practice
Background The complex relationship between clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and individual immune responses is not fully elucidated. Objective To examine phenotypes of symptomatology and their r
Autor:
Jonathan I. Silverberg, D. Ashley Hill, Elliot Frank, Abraham Pinter, Michael J. Joyner, Daniel Stok, Israel Zyskind, Aaron E. Glatt, Hiam Naiditch, Elliot Bigajer, Avi Z. Rosenberg, Jason Zimmerman, Elitza S. Theel, Miriam R. Lieberman
Publikováno v:
JAMA Network Open
Key Points Question Can severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks occur simultaneously across culturally bound minority communities? Findings In this cross-sectional study of 9507 ambulatory adults, a near simultaneous su
Publikováno v:
Dermatology online journal. 26(1)
Medical board organizations have accumulated large asset balances, in part due to the monetization of physician board recertification, as well as capital gains in positive investment conditions. Physicians across the country have raised concerns rega
Publikováno v:
NeoReviews. 16:e26-e35
Birthmarks are common skin lesions found in the newborn population. The most commonly encountered birthmarks include the pigmented, the hamartomatous and the vascular birthmarks. Each of these birthmarks may represent normal cutaneous variants with n
Publikováno v:
Dermatology online journal. 22(3)
Pemphigus foliaceus (PF) is a sporadic autoimmune blistering disease of unknown etiology. The production of immunoglobulin G4 antibodies against desmoglein-1 is responsible for the clinical manifestation of PF. We present a case of a woman with a rec
Publikováno v:
Liebman, Tracey N; Lieberman, Miriam R; & Burris, Katy. (2016). Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis. Dermatology Online Journal, 22(3). Retrieved from: http://www.escholarship.org/uc/item/50p1246h
Pemphigus foliaceus (PF) is a sporadic autoimmune blistering disease of unknown etiology. The production of immunoglobulin G4 antibodies against desmoglein-1 is responsible for the clinical manifestation of PF. We present a case of a woman with a rec
Autor:
Miriam R, Lieberman, Daniel M, Siegel
Publikováno v:
Dermatology online journal. 21(3)
The Maintenance of Certification (MOC) program proposed by the American Board of Medical Specialties (ABMS) gained approval in 2006. The implementation of this program will impact all physicians who are board certified. Therefore, The Financial Statu
Autor:
Daniel M. Siegel, Miriam R. Lieberman
Publikováno v:
Lieberman, Miriam R.; & Siegel, Daniel M.(2015). Maintenance of certification and the financial status of the medical boards. Dermatology Online Journal, 21(3). Retrieved from: http://www.escholarship.org/uc/item/02p697p4
Background: The Maintenance of Certification (MOC) program proposed by the American Board of Medical Specialties (ABMS) gained approval in 2006. The implementation of this program will impact all physicians who are board certified. Therefore, The Fin
Publikováno v:
Dermatology online journal. 21(2)
Anti-tumor necrosis factor induced lupus (ATIL) is a rare side effect reported in patients treated with anti-tumor necrosis factor medications such as infliximab, etanercept and adalimumab. Of the three, this condition has been least commonly reporte